EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery

Raluca Maria Furnica iD, France Devuyst, Céline Mathey, Stefan Matei Constantinescu, Carlien De Herdt, Orsalia Alexopoulou, Renaud Lhommel, Dominique Maiter

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Raluca Maria Furnica und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc UCL, 1200 Bruxelles, Belgium. Hauptthemen laut MEDLINE: Pituitary ACTH Hypersecretion, Positron Emission Tomography Computed Tomography, Methionine, ACTH-Secreting Pituitary Adenoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Doctoral Fellowship of the Belgian Fonds National de la Recherche Scientifique.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Equivocal or negative pituitary magnetic resonance imaging (MRI) findings pose a significant challenge in the management of persistent or recurrent Cushing disease (CD), compromising the chances of success of further transsphenoidal surgery (TSS).

Objective

To determine the diagnostic utility of 11C-methionine (11C-MET) positron emission tomography/computerized tomography (PET/CT) in localizing residual or relapsing corticotroph adenoma.

Methods

We retrospectively analyzed the results of all 11C-MET PET/CT performed at 2 tertiary medical centers between May 2002 and November 2023 in 22 patients with persistent/recurrent CD after initial TSS and equivocal/negative pituitary MRI. In 15 cases, 11C-MET PET/CT images were also co-registered with high-resolution 3D T1 or FLAIR MRI pituitary imaging.

Results

Of 22 patients (18 female; mean age 36 years at diagnosis; mean initial tumor maximum diameter 6.5 mm), 13 had a suspect anomaly on conventional MRI and 9 had a negative MRI. Maximal metabolic activity in the suspect area (SUVmaxT) was found in 14 patients (63.5%; 5/9 patients with negative pituitary MRI and 9/13 with equivocal findings). Based on positive imaging, 12 patients underwent repeat TSS, successful in 7, while 2 patients underwent Gamma Knife radiosurgery (GKRS), both resulting in remission (total remission rate of 64%). Among the 5 patients not cured by TSS, the presence of corticotroph adenoma in the resected tissue was found in 3 cases. Positive 11C-MET PET/CT had a detection rate accuracy of 86% (12/14). Of the 8 PET-negative patients, 2 underwent exploratory TSS, with no remission, and 2 underwent GKRS, with 1 long-term remission.

Conclusion

11C-MET PET/CT imaging can provide valuable diagnostic information to detect a corticotroph microadenoma in more than half of patients with persistent/recurrent CD and equivocal or negative MRI findings, allowing targeted TSS or radiosurgery with a global success rate of 64% in the selected subgroup with positive imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary ACTH HypersecretionPositron Emission Tomography Computed TomographyMethionineACTH-Secreting Pituitary AdenomaNeoplasm Recurrence, LocalAdenomaHumansFemaleMaleAdultRetrospective StudiesMiddle AgedMagnetic Resonance ImagingYoung AdultCarbon RadioisotopesAdolescent

Stichwörter der Autor:innen

11C-Methionine PET/CTfunctional imagingpersistent/recurrent Cushing diseasetherapeutic intervention

Substanzen

MethionineCarbon Radioisotopescarbon-11 methionine

Autor:innen und Institutionen

  • Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc UCL, 1200 Bruxelles, Belgium.
  • Department of Endocrinology, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, 1070 Bruxelles, Belgium.
  • Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, 1070 Bruxelles, Belgium.
  • Department of Endocrinology, Diabetology and Metabolism, University Antwerpen, 2650 Edegem, Belgium.
  • Department of Nuclear Medicine, Cliniques Universitaires Saint-Luc UCL, 1200 Bruxelles, Belgium.

ORCID-Profile: Raluca Maria Furnica

Förderung

  • Doctoral Fellowship of the Belgian Fonds National de la Recherche Scientifique

Zitieren

APA

Furnica, R. M., Devuyst, F., Mathey, C., Constantinescu, S. M., De Herdt, C., Alexopoulou, O., Lhommel, R., & Maiter, D. (2025). Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf047

Vancouver

Furnica RM, Devuyst F, Mathey C, Constantinescu SM, De Herdt C, Alexopoulou O, et al. Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf047

BibTeX
@article{Furnica2025,
  author = {Furnica, Raluca Maria and Devuyst, France and Mathey, Céline and Constantinescu, Stefan Matei and De Herdt, Carlien and Alexopoulou, Orsalia and Lhommel, Renaud and Maiter, Dominique},
  title = {Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf047}
}
Kostenlos starten →